Skip to main content
Equibles

MDNAF · Medicenna Therapeutics Corp. · Financials

Track MDNAF — free

Use MDNAF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MDNAF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.31 +0.03 (+9.40%) At close · Sep 18
Rebalance outlook locked
Market Cap
$27.41M
Shares
92.30M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Pull these statements through the financial statements API or MCP →
Net Income
-10.05M +55.5%
FY2023 Net Income FY2020–FY2023
Operating Cash Flow
-23.58M -54%
FY2022 Operating Cash Flow FY2020–FY2022

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2023 FY2022 FY2021 FY2020
CAD 9.3M 14.72M 10.87M 5.87M
CAD 7M 7.76M 6.53M 2.38M
CAD 5000 37K 40K 8000
CAD -10.05M -22.58M -17.29M -8.28M
CAD 0 0 0 0
CAD -10.05M -22.58M -17.29M -8.28M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.

Key facts CIK 1807983 CUSIP 58490H107 Visit website Investor relations